[Strategic Guide] Cross-Examining Hospital Defense Medical Experts Who Claim "Genetic Abnormalities"

#Strategic #Guide #CrossExamining #Hospital #Defense #Medical #Experts #Claim #Genetic #Abnormalities

2019 Guidance for Healthcare Professionals Acting as Expert Witnesses - What do you need to do now by Bond Solon

Title: 2019 Guidance for Healthcare Professionals Acting as Expert Witnesses - What do you need to do now
Channel: Bond Solon
[How-To] How To Book A Confidential In-Person Or Phone Legal Review For Your Surgery Injuries

Dismantling the "Genetic Alibi": A Trial Lawyer's Guide to Cross-Examining Hospital Defense Experts

The Rise of the Genetic Defense in Birth Injury Litigation

For decades, medical malpractice defense firms relied on a predictable menu of excuses. If a baby suffered profound brain damage during labor, the defense would blame an undetectable, pre-existing maternal infection. If that did not stick, they would point to an alleged "silent placental abruption" or perhaps some vague, unprovable cord accident that occurred days before the mother ever set foot in the labor and delivery suite. But we live in the era of genomic medicine, and the defense playbook has evolved. Today, when a hospital realizes its obstetrical staff ignored a category III fetal heart rate tracing for three hours, they do not just look at the placenta—they sequence the child’s DNA.

They call it the "genetic alibi." It is a highly sophisticated, incredibly expensive, and deeply cynical strategy designed to shift the blame from human error to molecular destiny. The script is always the same: the defense hires a high-priced geneticist from a prestigious academic medical center who walks into court with a glossy PowerPoint presentation, points to a single, microscopic variation in the child’s genetic code, and tells the jury, "This tragedy was written in the stars long before this mother ever went into labor." They want the jury to believe that the delayed C-section, the excessive Pitocin, and the profound lack of oxygen at birth were completely irrelevant.

I remember the first time I ran head-first into this tactic in a trial in Cook County. Our client was a beautiful six-year-old boy with spastic quadriplegic cerebral palsy, microcephaly, and a seizure disorder. The fetal monitor strips from his birth looked like a horror movie—deep, prolonged decelerations with virtually no variability for the final two hours of labor. Yet, three weeks before the discovery cutoff, the defense dropped a supplemental expert report containing a Whole Exome Sequencing (WES) analysis. They claimed to have found a "de novo mutation" on a gene no one in my office had ever heard of. Suddenly, we weren't just arguing about Pitocin titration; we were forced to litigate the outer frontiers of molecular biology.

It was a terrifying moment, but it taught me a fundamental truth: the genetic defense is almost always an illusion built on a foundation of scientific overreach and statistical manipulation. Hospitals are weaponizing the inherent complexity of the human genome to create reasonable doubt in the minds of jurors who are understandably overwhelmed by scientific jargon. As plaintiff's attorneys, we cannot afford to be intimidated. We have to become the educators in the courtroom, pulling back the curtain on this high-tech shell game and showing the jury that a spelling error in a child's DNA does not give a hospital a license to commit medical malpractice.

From "Bad Obstetrics" to "Bad DNA": The Defense's Favorite Pivot

The transition from clinical defenses to genetic defenses represents a seismic shift in how hospitals litigate birth trauma cases. In the past, a defense expert had to look a jury in the eye and try to explain why a doctor did not perform an emergency delivery despite a fetal heart rate that was flatlining. It was an uphill battle. Juries understand what a slow heart rate means; they understand that oxygen is life. But when the defense introduces genetics, they successfully shift the focus of the trial from the cold, clinical reality of the delivery room to an abstract, microscopic world where everything is governed by probability and mystery.

This pivot is incredibly attractive to defense counsel because it plays into a deep-seated cultural myth: the myth of genetic determinism. We have been conditioned by popular science, television shows, and direct-to-consumer DNA marketing to believe that our genes are an absolute blueprint for our lives. If a child has a "mutation," the average layperson naturally assumes that the mutation is the cause of whatever neurological deficits the child exhibits. The defense exploits this cognitive shortcut, hoping the jury will ignore the overwhelming clinical evidence of birth asphyxia—the low Apgar scores, the profound metabolic acidosis, the multi-organ system failure—and focus instead on a string of letters and numbers on a laboratory report.

To execute this pivot, defense firms have built a specialized cottage industry of "go-to" geneticists, pediatric neurologists, and neuroradiologists who travel the country testifying in these cases. These experts are not treating physicians; they are highly paid forensic consultants who spend their lives scouring genomic databases to find any variant they can use to construct a defense. They use sophisticated software to analyze raw genetic data, looking for rare variants that have never been studied in human clinical trials, and then they write authoritative-sounding reports claiming these variants are "pathogenic." It is a brilliant strategy, but only if we let them get away with it.

Our job is to stop this pivot in its tracks by exposing the sheer opportunism of the defense's sudden interest in genetics. We must show the jury that the hospital did not care about the child’s genetics when they were mismanaging the labor, nor did they care during the first five years of the child's life. It was only when a multi-million-dollar lawsuit was filed that the defense suddenly decided to play genetic detective. When you frame the genetic defense not as a legitimate scientific inquiry, but as a litigation-driven search for an escape hatch, the jury's perspective shifts from awe to skepticism.

The Psychology of the Jury When Genetics Are Introduced

Understanding how jurors process genetic evidence is critical to designing your cross-examination. For the average juror, genetics represents a paradox: it is simultaneously perceived as "hard, objective science" and as an utterly incomprehensible foreign language. When a defense expert stands up and starts talking about heterozygous missense mutations, copy number variants, and highly conserved amino acid sequences, the typical juror's eyes glaze over. But even as they lose track of the technical details, a dangerous psychological phenomenon occurs—they begin to defer to the expert’s perceived authority.

This deference is rooted in fear. Jurors are terrified of making a mistake, and when faced with overwhelming scientific complexity, their natural instinct is to cling to the expert who speaks with the greatest degree of certainty. The defense expert knows this, which is why they present their genetic findings with absolute, unwavering confidence. They do not say, "This variant might have played a role." They say, "This child has a catastrophic genetic syndrome that made severe neurological impairment inevitable, regardless of the quality of the obstetrical care." It is a powerful, comforting narrative for a juror who is looking for an easy way to resolve a complex, emotionally draining case.

To combat this, we must demystify the science. We have to show the jury that genetics is not a magic wand that explains away all human suffering, but a young, rapidly evolving field filled with uncertainty, debate, and massive gaps in knowledge. We must teach them that having a genetic variant is not the same thing as having a disease. Every single person in that courtroom, including every juror, every lawyer, and the judge, carries thousands of genetic mutations, yet most of us live normal, healthy lives. Once the jury understands that "genetic variation" is simply the scientific term for human individuality, the defense’s genetic house of cards begins to wobble.

Furthermore, we must tap into the jury’s natural sense of fairness and common sense. Juries are highly intuitive. They know what a brain looks like when it is starved of oxygen, and they know what happens when a baby is stuck in the birth canal for hours. If you can juxtapose the clinical reality of the birth—the blue, limp baby who required immediate resuscitation—with the defense's abstract genetic theories, the jury will almost always choose common sense over molecular speculation. Your cross-examination must constantly bridge this gap, contrasting the defense expert's theoretical genetics with the raw, undeniable clinical facts of the injury.

Insider Note

Never let the defense expert control the vocabulary of the trial. If they use the term "mutation," gently but firmly correct them on cross-examination to "variant." A "mutation" sounds like an active, destructive disease process; a "variant" sounds like what it actually is—a natural difference in the genetic code. The American College of Medical Genetics and Genomics (ACMG) explicitly recommends using the term "variant" rather than "mutation" to avoid misleading clinical interpretations. Weaponize their own professional guidelines against them from the very first question.

Anatomy of the Genetic Defense: Variant of Uncertain Significance (VUS) and Other Trapdoors

To cross-examine a defense geneticist effectively, you must understand the rules of their own game. Genetic testing in birth injury cases typically involves Whole Exome Sequencing (WES) or Whole Genome Sequencing (WGS). These tests sequence millions of base pairs of DNA, comparing the child's genetic code to a standard reference genome. Because no two humans are identical, the testing will inevitably reveal hundreds, if not thousands, of differences between the child's DNA and the reference genome. The lab must then classify these differences, and this is where the defense finds its playground.

The American College of Medical Genetics and Genomics (ACMG) has established a strict, five-tier classification system for genetic variants:

Pathogenic
Likely Pathogenic
Variant of Uncertain Significance (VUS)
Likely Benign
Benign

[ACMG Classification Spectrum]
Benign <---> Likely Benign <---> VUS <---> Likely Pathogenic <---> Pathogenic
                                  ^
                     (The Defense's Playground)

The vast majority of rare genetic variants discovered in these cases fall squarely into the third category: Variant of Uncertain Significance (VUS). A VUS is exactly what it sounds like—a genetic change where the scientific community simply does not know whether it causes disease or is completely harmless. It is the scientific equivalent of a question mark. Yet, in the hands of a skilled defense expert, this question mark is magically transformed into an exclamation point. They will take a VUS on a gene vaguely associated with neurological development and present it to the jury as the definitive, undisputed cause of the child's cerebral palsy.

Your primary objective when dealing with a VUS defense is to expose this transformation as scientifically fraudulent. Under the ACMG guidelines, which are accepted by every reputable geneticist in the world, a VUS must not be used for clinical decision-making or diagnosis. The guidelines explicitly state that a VUS should not be considered "causative" of a patient's condition unless and until further, definitive scientific evidence emerges. When a defense expert stands up in court and diagnoses a child with a genetic syndrome based on a VUS, they are violating the fundamental ethical and scientific standards of their own profession.

Unmasking the VUS: The Danger of "Unknown Significance"

When you cross-examine the defense expert on a VUS, you must be relentless in highlighting the word "uncertain." I like to write the words "Variant of Uncertain Significance" on a large foam board or a digital display and leave it in front of the jury for the entire cross-examination. I want the jury to see that word—uncertain—every single time they look at the witness. You must force the expert to admit, under oath, that "uncertain" means exactly what it says: the medical community does not know what this variant does.

Start by walking the expert through the ACMG classification criteria. Force them to admit that the laboratory that actually ran the test—a laboratory staffed by objective, non-litigation-retained scientists—classified this variant as a VUS because there was insufficient evidence to call it pathogenic. The lab did not say it was the cause of the child’s cerebral palsy; the lab said, "We don't know." It is incredibly powerful to contrast the objective, cautious language of the testing laboratory with the bold, absolute assertions of the expert who is being paid $10,000 a day to testify for the hospital.

The "We Don't Know" concession: Force the expert to admit that there are no peer-reviewed studies linking this specific variant to the child's specific clinical presentation.
The population database trap: Use databases like gnomAD to show that this "rare" variant actually exists in healthy, normal individuals in the general population.
The parental testing shield: If the parents were tested (trio sequencing) and one of them carries the exact same VUS but is completely healthy and normal, the defense’s theory is dead in the water.
The laboratory disclaimer: Every genetic report has a disclaimer section in tiny print. Find it, blow it up, and read it to the jury. It will invariably state that a VUS should not be used for diagnostic purposes.

Once you have established these points, you can systematically dismantle the expert's credibility. You are not arguing science with them; you are holding them to the standards of their own scientific community. You are showing the jury that the expert has abandoned scientific rigor in favor of advocacy. They are asking the jury to make a multi-million-dollar decision based on a genetic finding that their own colleagues would not use to treat a patient in a clinic.

Phenotype vs. Genotype: The Critical Disconnect

One of the most powerful ways to defeat a genetic defense is to expose the massive chasm between the child's "genotype" (their genetic makeup) and their "phenotype" (their actual, physical clinical presentation). The defense expert will focus entirely on the genotype, trying to convince the jury that because there is a mutation on a specific gene, the child must have the disease associated with that gene. But biology does not work that way. The human body is incredibly complex, and the presence of a genetic variant does not automatically dictate the physical outcome.

To exploit this disconnect, you must become an expert on the specific gene in question. Let's say the defense is claiming a mutation on the SCN1A gene is the cause of the child's neurological deficits. SCN1A is associated with Dravet syndrome, a severe form of epilepsy. You must research Dravet syndrome thoroughly. What are its classic clinical features? It usually presents with prolonged, febrile seizures in the first year of life, developmental regression, and ataxia. Now, look at your client. Did your client have febrile seizures in the first year of life? No. Did they have developmental regression? No, they have had a steady, albeit slow, developmental trajectory since birth. Is their MRI consistent with Dravet syndrome? No, their MRI shows classic, focal bilateral lesions in the basal ganglia and thalamus—the signature of acute, near-total hypoxic-ischemic encephalopathy (HIE).

When you present this contrast to the jury, the defense's genetic theory crumbles. You are showing them that the child's clinical picture does not fit the genetic mold. The defense is trying to force a square peg into a round hole. They are ignoring the living, breathing child in front of them and focusing instead on a theoretical disease described in a textbook. Use the treating physicians—the pediatricians, the neurologists, the therapists who actually care for the child—to establish the clinical reality, and then use the cross-examination of the defense geneticist to highlight just how divorced their theories are from that reality.

[The Clinical Disconnect]
Defense Theory (Genotype) -------------> Textbook Disease (e.g., Dravet Syndrome)
                                                |
                                          (MASSIVE GAP)
                                                v
Clinical Reality (Phenotype) ----------> Acute HIE (Basal Ganglia/Thalamus Lesions)

I remember a cross-examination where I asked the defense geneticist to list the top ten clinical symptoms of the genetic syndrome he claimed the child had. He listed them, one by one, on the butcher paper. I then had him go through the child’s medical records and check off how many of those ten symptoms the child actually exhibited. The answer was zero. Not a single one. By the end of that line of questioning, the jury could see that the expert’s diagnosis was a complete work of fiction. He was diagnosing a disease that existed only on paper, while ignoring the profound brain injury that was documented in every single page of the hospital records.

Pro-Tip

When researching the specific gene cited by the defense, always check the ClinVar database (maintained by the National Institutes of Health). ClinVar is a free, publicly accessible archive of reports of the relationships among human variations and phenotypes. It will show you how different laboratories around the world have classified that specific variant. If five other major academic labs have classified the variant as "benign" or "likely benign," while the defense lab called it a "VUS" or "pathogenic," you have gold-standard evidence of scientific bias.

Pre-Trial Preparation: Weaponizing the Medical Records and Depositions

You cannot win a genetic cross-examination on the fly. The battle is won or lost in the months leading up to trial, specifically during the discovery phase and the expert depositions. If you wait until the trial to figure out the weaknesses in the defense's genetic theory, you have already lost. You must approach pre-trial preparation with a systematic, aggressive strategy designed to trap the defense expert in their own words before they ever set foot in front of a jury.

The first step is to obtain the raw genetic data. When a hospital performs genetic testing, they will typically only produce the final, clinical report. This report is a summarized, sanitized version of the findings. You must demand the raw data files—specifically the FASTQ, BAM, and VCF files. These files contain the actual, unedited sequencing data and the bioinformatic filtering pipelines used by the laboratory. If you do not have these files, your own consulting geneticist cannot independently verify the defense's claims.

I once had a case where the defense's clinical report claimed a child had a pathogenic mutation. When we forced them to produce the raw VCF file and had our expert analyze it, we discovered that the "mutation" was actually a sequencing artifact—a technical error made by the machine during the sequencing process. The defense expert had built an entire causation defense on a glitch in a computer program. If we had not fought for the raw data, we would have walked into trial completely blind to this fact.

Once you have the raw data and your own expert has analyzed it, you must prepare for the deposition of the defense geneticist. This deposition is the most critical event in the entire litigation. Your goal in the deposition is not to argue with the expert or try to get them to change their mind; your goal is to pin them down, limit their escape routes, and force them to make concessions that you can weaponize at trial. You want to build a cage of admissions around them, so that when they get to trial, any attempt to wiggle out of their deposition testimony will destroy their credibility.

Digging Into the Sequencing Data: Whole Exome vs. Whole Genome

To effectively weaponize the medical records, you must understand the technical differences between Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS). The human genome consists of approximately 3 billion base pairs of DNA, but only about 1% to 2% of that DNA actually codes for proteins. This protein-coding region is called the "exome." WES only sequences this 1% to 2%, ignoring the rest of the genome. WGS, on the other hand, sequences the entire 3 billion base pairs, including the non-coding regions (often historically, and incorrectly, referred to as "junk DNA").

The defense almost always prefers WES because it is cheaper and easier to interpret. However, WES has massive blind spots. It cannot reliably detect large structural variations, copy number variants (CNVs), or mutations in regulatory regions of the DNA that control gene expression. If the defense expert is relying on a WES report to claim a genetic cause, you can use the limitations of WES to show that their analysis is incomplete. You can force them to admit that they are making a definitive diagnosis while ignoring 98% of the child’s genetic blueprint.

Exon skipping and coverage gaps: Exome sequencing often misses specific exons due to poor "coverage" (the number of times a specific base pair is read during sequencing). Force the expert to admit that the gene they are focusing on may have had incomplete coverage, meaning the test could have missed crucial information.
The re-analysis hustle: Hospitals often run genetic tests years after the birth, and then "re-analyze" the data multiple times. Show the jury how many times the data was re-run before the defense finally found a variant they could use. This exposes the "litigation-driven" nature of the science.
The lack of functional studies: A genetic variant is just a sequence of letters. To prove it causes disease, you need "functional studies"—wet-lab experiments showing that the mutated gene actually produces a dysfunctional protein in living cells. Ask the expert if any functional studies have been performed on this child’s specific variant. The answer will almost certainly be no.

By mastering these technical details, you establish yourself as an authority. The defense expert will realize very quickly that they cannot baffle you with bullshit. They will see that you understand the technology just as well as they do, which immediately puts them on the defensive and makes them much more cautious in their assertions.

Deposition Strategies: Pinning Down the Expert Before They Step in the Courtroom

When you depose the defense geneticist, you must use a "funnel" questioning technique. Start broad, establishing general scientific principles that they must agree with, and then gradually narrow the focus until they are trapped. If you start with the specific genetic variant in your case, they will immediately go on the defensive and start spinning the science. You must get them to commit to the rules of the road before they realize where you are taking them.

For example, start by getting them to agree to standard, uncontroversial principles of pediatric neurology and neonatology. Get them to admit that hypoxic-ischemic encephalopathy (HIE) is a well-recognized medical condition. Get them to admit that HIE causes characteristic brain damage that can be seen on an MRI. Get them to admit that the timing of an brain injury can be determined with a high degree of accuracy using diffusion-weighted MRI imaging. Once they have agreed to these clinical realities, you can move to genetics.

[The Deposition Funnel]
1. Establish general clinical principles (HIE is real, MRI timing is reliable)
  \                                                                       /
   \ 2. Establish ACMG rules (VUS cannot be used for clinical diagnosis) /
    \                                                                   /
     \ 3. Bind them to the child's specific, non-matching clinical facts /
      \                                                                 /
       v 4. The Trap: Force them to choose between clinical reality and genetic theory

Next, walk them through the ACMG guidelines. Get them to admit, in a general sense, that the ACMG guidelines are the gold standard for genetic interpretation. Get them to agree that a VUS is defined as "uncertain" and that using a VUS to make a clinical diagnosis is contrary to safe medical practice. Only after you have secured these admissions do you bring up the child in your case. Now, when they try to claim that the child’s VUS is the sole cause of their cerebral palsy, they are in direct conflict with the very guidelines they just admitted are the gold standard.

Finally, force them to commit to a binary choice: either the child’s clinical presentation is a perfect match for the genetic syndrome they are claiming, or it is not. If they claim it is a match, you will dismantle them at trial by showing all the ways it is not. If they admit it is not a perfect match, you have successfully introduced doubt into their theory. Either way, you win.

Commitment to ACMG: "Doctor, do you agree that the ACMG guidelines are the authoritative standard for interpreting genetic variants?"
The VUS definition: "Do you agree that, by definition, a Variant of Uncertain Significance lacks sufficient scientific evidence to be classified as pathogenic?"
The clinical prohibition: "Is it your opinion that a clinical geneticist should diagnose a patient with a genetic disease based solely on a VUS in a clinical setting?"
The specific variant: "The laboratory that sequenced my client's DNA classified this specific variant as a VUS, correct?"
The gap in literature: "Can you point me to

[Market Watch] Venture-Backed Medical-Legal Research Platforms Accelerating Birth Injury Case Reviews

Defendant's Medical Expert Ruined on Cross-Examination by Gerry Oginski

Title: Defendant's Medical Expert Ruined on Cross-Examination
Channel: Gerry Oginski
[Data Insight] 75% Of Compensable Hospital Errors Occur During Surgical Procedures And Recovery

Medical Experts in the Family Court Where Two Worlds Collide by Gresham College

Title: Medical Experts in the Family Court Where Two Worlds Collide
Channel: Gresham College

Medical EmExome A Strategy for Diagnosing Patients with Genetic Disorders by EGL Genetics

Title: Medical EmExome A Strategy for Diagnosing Patients with Genetic Disorders
Channel: EGL Genetics